Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
154 studies found for:    "Pneumonia, Ventilator-Associated"
Show Display Options
RSS Create an RSS feed from your search for:
"Pneumonia, Ventilator-Associated"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
Conditions: Methicillin-resistant Staphylococcus Aureus;   Pneumonia, Ventilator-Associated
Intervention: Drug: Imipenem/cilastatin
2 Completed Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation Therapy
Condition: Pneumonia, Ventilator-Associated
Intervention: Procedure: Continuous lateral rotation therapy
3 Completed Prehospital Ventilator-Associated Pneumonia Prevention Trial
Conditions: Wounds and Injuries;   Respiratory Failure;   Pneumonia, Ventilator-Associated
Intervention: Drug: Chlorhexidine gluconate
4 Completed Time Interval for Changing Closed System Suction Catheters, Effect on Ventilator Associated Pneumonia
Conditions: Pneumonia, Ventilator Associated;   Closed System Suction Catheter
Intervention: Device: Closed system suction
5 Completed Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus
Condition: Pneumonia, Ventilator-Associated
Interventions: Drug: Vancomycin;   Drug: Linezolid
6 Unknown  Ventilator-Associated Pneumonia (VAP) in Intensive Care Unit (ICU)
Condition: Ventilator-Associated Pneumonia
Intervention:
7 Completed Prevention of Ventilator-Associated Pneumonia by Automatic Control of the Tracheal Tube Cuff Pressure
Conditions: Ventilator-Associated Pneumonia;   Mechanical Ventilation
Intervention: Device: Automatic control of tracheal tube cuff pressure
8 Unknown  Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU Patients
Condition: Ventilator Associated Pneumonia
Interventions: Device: Taper Guard Endotracheal Tube;   Other: Conventional endotracheal tube
9 Recruiting Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP)
Condition: Ventilator-associated Pneumonia
Interventions: Drug: Chlorhexidine;   Drug: 0.9% sodium chloride injection;   Device: Endotracheal tube;   Device: Fiber bronchoscope
10 Suspended Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological Patients
Condition: Ventilator Associated Pneumonia
Interventions: Drug: Sultamicillin;   Drug: Physiologic Sodium Chloride Solution as placebo
11 Recruiting Diagnostic Value of Lung Ultrasound for Ventilator-Associated Pneumonia
Condition: Ventilator-Associated Pneumonia
Intervention: Other: Lung ultrasound examination
12 Completed The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia
Condition: Ventilator-Associated Pneumonia
Intervention: Drug: Imipenem
13 Completed Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia
Conditions: Pneumonia;   Ventilator Associated Pneumonia
Interventions: Dietary Supplement: Lactobacillus GG;   Dietary Supplement: placebo
14 Not yet recruiting Study of Different Etiologic Diagnostic Methods in Ventilator Associated Pneumonia (VAP)
Condition: Ventilator Associated Pneumonia
Intervention: Procedure: Collect tracheal and pulmonary secretions
15 Terminated The Diagnostic and Prognostic Utility of Procalcitonin (ProCT) for Ventilator-associated Pneumonia (VAP)
Condition: Ventilator Associated Pneumonia
Intervention: Device: PROCALCITONIN LEVEL
16 Unknown  Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke
Conditions: Ventilator-associated Pneumonia;   Ischemic Stroke
Interventions: Drug: Atorvastatin;   Drug: Placebo
17 Completed The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia
Condition: Ventilator-Associated Pneumonia
Intervention: Drug: Doripenem
18 Completed Study of Knowledge Translation of Clinical Practice Guidelines for Ventilator Associated Pneumonia
Condition: Ventilator Associated Pneumonia
Intervention: Behavioral: Education
19 Withdrawn Bronchoscopy vs. Clinical Pulmonary Infection Score Guided Approach in Suspected Ventilator-Associated Pneumonia (VAP)
Condition: Ventilator Associated Pneumonia
Interventions: Procedure: Bronchoscopy;   Procedure: Clinical pulmonary infection score (CPIS)
20 Completed A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia
Conditions: Ventilator Associated Pneumonia;   Etiological Organisms;   Antimicrobial Drug Susceptibility Pattern;   Stress Ulcer Prophylaxis
Interventions: Drug: Ranitidine;   Drug: Sucralfate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years